Stock screenerAll disclosures →
EDGAR →
ABUS
Conviction 62HealthcareScan · Mon, Aug 10, 2026ABUS$4.62-0.32%
ResistanceSupportVol 14Vol MA14 1.23M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price4.62
Change-0.32%
Gap+0.76%
Rel volume1.15×
Avg volume1.45M
Avg $ vol6.51M
SMA 204.48
SMA 504.52
SMA 2004.45
Price vs 50+2.01%
Price vs 200+3.67%
MA stackbullish
50/200 cross—
Supertrenddown · 4.92
RSI (14)54
MACD hist0.02
MACD crossbull · 2d
Stoch %K / %D83 / 78
ADX (14)15
+DI / −DI21 / 16
RSI divergence—
MACD divergenceBullish
ATR %+3.97%
ADR %3.78%
52w high5.22
52w low3.35
From 52w high-11.59%
Above 52w low+37.76%
New 52w highNo
SqueezeOn · 3d
Bollinger width10.72%
%B0.78
Donchian pos61.86%
Donchian high4.84
Donchian low4.25
AVWAP (52w high)4.60
vs AVWAP high+0.30%
AVWAP (52w low)4.43
vs AVWAP low+4.15%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d1.15×
Avg vol (14d)1.23M
Avg vol (20d)1.45M
Avg $ vol (20d)6.51M
Market cap911.64M
RS 3m (vs SPY)+0.74%
RS 6m (vs SPY)+12.04%
RS line new highNo
Trend template6/8
Technical rank54.7
1 week+5.85%
1 month-3.85%
3 months+6.34%
6 months+20.18%
1 year+35.74%
YTD-3.25%
P/E-27.21
P/B3.50
P/S64.73
P/FCF-23.00
EPS-0.1700
Div yield—
ROE-12.88%
ROA-12.09%
Debt/Eq0.00
Current54.26
EV/EBITDA—
Gross margin—
Net margin-237.88%
Rev growth128.21%
EPS growth52.09%
Price target—
Target upside—
Analyst rating—
Institutional76.58%
Ent. value887.93M
Revenue179.13M
Net income169.69M
Gross profit—
Free cash flow-39.64M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out197.54M
Employees19
ListedThu, Jul 26, 2007
Free float156.47M
Float %79.5%
Short interest19.65M
Days to cover7.4d
Short volume65.7%
Squeeze score69 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.87
Last surprise—
Setup gradeB
Conviction62 / 100
Pattern quality—
Tech rank54.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.11
Support4.26
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ABUS
No recent disclosed trades by Congress in ABUS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ABUS · 2 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sawhney Roger Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 78.8K | $0 | 2026-06-08 | 2026-06-10 |
Beardsley Robert A Director · Stock Option (Right to Buy) · 2026-06-08 | Grant | 78.8K | $0 | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in ABUS · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.